Literature DB >> 33489484

COVID-19 in Patients With Hematologic-Oncologic Risk Factors: Complications in Three Patients.

Dawood Tafti1, Matthew Kluckman1, Michael C Dearborn1, John Hunninghake2, Sara Clayton1.   

Abstract

The novel COVID-19 infection has demonstrated a spectrum of complications involving vascular, inflammatory, infectious, and metabolic conditions. These complications range from mild loss of smell to more severe acute respiratory distress syndrome (ARDS). Patients with more severe complications often require sedation and mechanical ventilation. Growing research has revealed the role of active malignancy and disease-in-remission status as possible risk factors contributing to the morbidity and mortality in COVID-19 patients. In our descriptive case series, we present three unique cases of complicated COVID-19 infection in patients with hematologic-oncologic risk factors and review the imaging features of their complications. The first patient was a 33-year-old male with sickle cell trait who developed rhabdomyolysis and myonecrosis of the paraspinal muscle in the setting of a physical fitness test; he subsequently developed an abscess at this site, presumably exacerbated by the hypoxemic state of his COVID-19 pneumonia. Our second patient was a 37-year-old male with COVID-19 pneumonia and a history of stage IV Non-Hodgkin's lymphoma in remission who developed spontaneous pneumomediastinum in the absence of positive pressure ventilation. The third COVID-positive patient was a 54-year-old male with a past medical history significant for grade 1 follicular non-Hodgkin's lymphoma in remission with sputum culture positive for mycobacterium avium complex and bronchoscopy positive for candida growth. 18-FDG/PET imaging was performed and demonstrated diffuse intense uptake throughout the lungs reflecting both the COVID-19 pneumonia and the multimicrobial superinfection.
Copyright © 2020, Tafti et al.

Entities:  

Keywords:  covid-19; oncology; sickle cell trait

Year:  2020        PMID: 33489484      PMCID: PMC7805421          DOI: 10.7759/cureus.12064

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  17 in total

1.  COVID-19 infection and sickle cell disease: a UK centre experience.

Authors:  Kayleigh A McCloskey; John Meenan; Rhys Hall; Dimitris A Tsitsikas
Journal:  Br J Haematol       Date:  2020-06-17       Impact factor: 6.998

2.  COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes.

Authors:  R Lattenist; H Yildiz; J De Greef; S Bailly; J C Yombi
Journal:  Indian J Hematol Blood Transfus       Date:  2020-07-07       Impact factor: 0.900

3.  Sickle Cell Trait, Rhabdomyolysis, and Mortality among U.S. Army Soldiers.

Authors:  D Alan Nelson; Patricia A Deuster; Robert Carter; Owen T Hill; Vickee L Wolcott; Lianne M Kurina
Journal:  N Engl J Med       Date:  2016-08-04       Impact factor: 91.245

Review 4.  Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review.

Authors:  Daniel P Oran; Eric J Topol
Journal:  Ann Intern Med       Date:  2020-06-03       Impact factor: 25.391

5.  Splenic Syndrome in a Young Man at High Altitude with Undetected Sickle Cell Trait.

Authors:  Chka Fernando; S Mendis; A P Upasena; Y J Costa; H S Williams; D Moratuwagama
Journal:  J Patient Exp       Date:  2017-12-27

6.  Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation.

Authors:  Georgeann McGuinness; Chenyang Zhan; Noah Rosenberg; Lea Azour; Maj Wickstrom; Derek M Mason; Kristen M Thomas; William H Moore
Journal:  Radiology       Date:  2020-07-02       Impact factor: 11.105

7.  PET imaging of COVID-19: the target and the number.

Authors:  E Guedj; A Verger; S Cammilleri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04-17       Impact factor: 9.236

Review 8.  Case Report: Pneumothorax and Pneumomediastinum as Uncommon Complications of COVID-19 Pneumonia-Literature Review.

Authors:  Alvaro Quincho-Lopez; Dania L Quincho-Lopez; Fernando D Hurtado-Medina
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

9.  18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases.

Authors:  Chunxia Qin; Fang Liu; Tzu-Chen Yen; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-22       Impact factor: 9.236

10.  COVID-19 in persons with haematological cancers.

Authors:  Wenjuan He; Lei Chen; Li Chen; Guolin Yuan; Yun Fang; Wenlan Chen; Di Wu; Bo Liang; Xiaoting Lu; Yanling Ma; Lei Li; Hongxiang Wang; Zhichao Chen; Qiubai Li; Robert Peter Gale
Journal:  Leukemia       Date:  2020-04-24       Impact factor: 12.883

View more
  4 in total

Review 1.  Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.

Authors:  Wouter S Hoogenboom; Tharun T Alamuri; Daniel M McMahon; Nino Balanchivadze; Vrushali Dabak; William B Mitchell; Kerry B Morrone; Deepa Manwani; Tim Q Duong
Journal:  Blood Rev       Date:  2021-11-20       Impact factor: 10.626

2.  Effects of COVID-19 in lymphoid malignancies.

Authors:  Öner Özdemir
Journal:  World J Virol       Date:  2021-11-25

3.  Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report.

Authors:  Gabriele Donati; Chiara Abenavoli; Gisella Vischini; Giovanna Cenacchi; Roberta Costa; Gianandrea Pasquinelli; Manuela Ferracin; Noemi Laprovitera; Giorgia Comai; Giorgio Monti; Fabrizio Giostra; Gaetano La Manna
Journal:  Am J Case Rep       Date:  2022-02-23

Review 4.  Epidemiology of Systemic Mycoses in the COVID-19 Pandemic.

Authors:  María Guadalupe Frías-De-León; Rodolfo Pinto-Almazán; Rigoberto Hernández-Castro; Eduardo García-Salazar; Patricia Meza-Meneses; Carmen Rodríguez-Cerdeira; Roberto Arenas; Esther Conde-Cuevas; Gustavo Acosta-Altamirano; Erick Martínez-Herrera
Journal:  J Fungi (Basel)       Date:  2021-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.